RE:RE:RE:RE:RE:Small Sign: Clinical Trial For RVX-208 Soon To CommenceHi Jkj.
That's what I thought. Based on Don's Feb webcast I thought he referred to a $30,000,000,000 market in North America alone just on the MACE side.
AND that doesn't take into account the potential the diabetes, Alzheimers and all the other inflammatory diseases.
Well, my question is why isn't the trial happening right now?
GLTA tionv